In the past two decades, biopharmaceuticals have been a breakthrough in improving the
quality of lives of patients with various cancers, autoimmune, genetic disorders etc. With the …

Proteins and enzymes are versatile biomaterials for a wide range of medical applications
due to their high specificity for receptors and substrates, high degradability, low toxicity, and …

The global pharmaceutical market has recently shifted its focus from small molecule drugs to
peptide, protein, and nucleic acid drugs, which now comprise a majority of the top-selling …

Pandemics and epidemics are continually challenging human beings' health and imposing
major stresses on the societies particularly over the last few decades, when their frequency …

The inability of many biopharmaceutical formulations to retain their structure and integrity
when in solution represents a major issue for their transport and storage, reducing their shelf …

Biopharmaceuticals have established an indisputable presence in the pharmaceutical
pipeline, enabling highly specific new therapies. However, manufacturing, isolating, and …

Introduction The development of long-acting injectables (LAIs) for protein and peptide
therapeutics has been a key challenge over the last 20 years. If these molecules offer …

Bioactive peptides derived from enzymatic hydrolysis are gaining attention for the production
of supplements, pharmaceutical compounds, and functional foods. However, their inclusion …

Objective The therapeutic options for severe asthma are limited, and the biological therapies
are all parenterally administered. The purpose of this study was to formulate a monoclonal …

Background Most biopharmaceuticals are developed in liquid dosage forms that are less
stable than solid forms. To ensure the stability of biopharmaceuticals, it is critical to use an …